MLKL and metabolic disease: These results, combined with the distinct phenotype of adipocyte hypertrophy and fatty liver damage observed in aged or HFD-fed MLKL-deficient mice, suggest that MLKL alters tissue homeostasis to cause obesity-induced metabolic disease.